Stides Vivimed gets USFDA approval for Albendazole Tablets

Vivimed Labs announced that its 50:50 JV Strides Vivimed, Singapore has received approval for Albendazole Tablets USP 200mg from the united States Food & Drug Administration (USFDA). This is the second generic approval by USFDA for Albendazole Tablets.

Albendazole Tablets is a generic version of Albenza Tablets@ of Amneal pharmaceuticals, Inc. According to IQVIA MAT data, the US market for Albendazole Tablets USP 200 mg is approximately US$ 100 Mn.

Powered by Capital Market - Live News